ML133 HCl: Selective Kir2.1 Channel Blocker in Cardiovasc...
2025-10-21
ML133 HCl is a highly selective potassium channel inhibitor that delivers unmatched precision for studying Kir2.1-mediated cellular mechanisms. Its optimized solubility profile and proven efficacy in pulmonary artery smooth muscle cell proliferation research make it indispensable for cardiovascular disease modeling and translational ion channel studies.